Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × avelumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Metastatic Urothelial Cancer 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

venetoclax 61 Azacitidine 51 Cytarabine 33 Specimen Handling 28 Biopsy 21 fludarabine 19 Daunorubicin 18 Injections 17 Decitabine 16 fludarabine phosphate 13 Cyclophosphamide 13 Whole-Body Irradiation 12 CPX-351 12 Idarubicin 11 Melphalan 10 Stem Cell Transplantation 9 Busulfan 9 gilteritinib 8 decitabine and cedazuridine drug combination 8 Mycophenolic Acid 8 Granulocyte Colony-Stimulating Factor 8 Magnetic Resonance Spectroscopy 7 Liposomes 7 Filgrastim 7 ivosidenib 6 enasidenib 6 Gemtuzumab 6 revumenib 5 olutasidenib 5 Mesna 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡